Stockreport

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025

Fulcrum Therapeutics, Inc.  (FULC) 
Last fulcrum therapeutics, inc. earnings: 3/5 07:00 am Check Earnings Report
PDF         ? Announced encouraging results in July 2025 from the 12 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ? ? Enrollment c [Read more]